Immunotherapy for the Treatment of Breast Cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11912-014-0426-9.pdf
Reference82 articles.
1. American Cancer Society. Cancer facts and figures. In: American Cancer Society, editor. Atlanta 2014.
2. Arnould L, Gelly M, Penault-Llorca F, Benoit L, Bonnetain F, Migeon C, et al. Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism? Br J Cancer. 2006;94(2):259–67. doi: 10.1038/sj.bjc.6602930 .
3. Sharma P, Wagner K, Wolchok JD, Allison JP. Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Nat Rev Cancer. 2011;11(11):805–12. doi: 10.1038/nrc3153 .
4. Pockaj BA, Basu GD, Pathangey LB, Gray RJ, Hernandez JL, Gendler SJ, et al. Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer. Ann Surg Oncol. 2004;11(3):328–39.
5. Wang ZX, Cao JX, Wang M, Li D, Cui YX, Zhang XY, et al. Adoptive cellular immunotherapy for the treatment of patients with breast cancer: a meta-analysis. Cytotherapy. 2014;16(7):934–45. doi: 10.1016/j.jcyt.2014.02.011 .
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunotherapeutic Strategies Targeting Breast Cancer Stem Cells;Current Oncology;2024-05-29
2. Association of ADP‑ribosylation factor family genes with prognosis and immune infiltration of breast cancer;Oncology Letters;2024-04-23
3. Designing of Coumarin molecules as EGFR inhibitors and their ADMET, MD Simulation Studies for Evaluating potential as Anticancer molecules;Research Journal of Pharmacy and Technology;2024-03-31
4. Amplifying Immune Responses: Microparticulate Vaccine Approach Against Breast Cancer;Breast Cancer: Targets and Therapy;2024-03
5. Breast cancer vaccination: Latest advances with an analytical focus on clinical trials;International Immunopharmacology;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3